^
BIOMARKER:

EGFR mutation + CDKN2A mutation

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor, CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Entrez ID:
News
Twitter
Trials
EGFR mutation + CDKN2A mutation
NSCLC
osimertinib
Resistant: C3 – Early Trials
EGFR mutation + CDKN2A mutation
NSCLC
Tyrosine kinase inhibitor
Sensitive: C3 – Early Trials